Early Changes in [¹⁸F]FDG Uptake as a Readout for PI3K/Akt/mTOR Targeted Drugs in HER-2-Positive Cancer Xenografts

Figure 6

Representative images of SKOV3 xenografts. Representative [¹⁸F]FDG PET/CT SUV-corrected images of mice exposed to mono- and combination therapy at baseline and after day 7. White arrows indicate tumors with SUV_max of that tumor. All mice were imaged in supine position.